Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Wellorithm vs NovoCare Pharmacy

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.2

Wellorithm

Best for compounded GLP-1 access with oral tablet options across 49 states
★★★3.6
Compounded SemaglutideCompounded TirzepatideOral Dissolving TabletsInjectable
Visit Wellorithm
8.7

NovoCare Pharmacy

Best for branded Wegovy at the lowest manufacturer-direct self-pay price
★★★★4.4

Starting at $199/mo

WegovyBrandManufacturer DirectAll 50 States
Visit NovoCare Pharmacy

Side-by-Side Comparison

FeatureWellorithmNovoCare Pharmacy
Overall Score7.2/108.7/10
Starting Price$199/mo
Editorial Rating3.6 ★ /54.4 ★ /5
Features4 features5 features
States Available4950
Compounded
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Wellorithm

Pros

  • Four compounded GLP-1 formats: semaglutide injectable, semaglutide oral dissolving tablets, tirzepatide injectable, tirzepatide oral dissolving tablets
  • Available in 49 states — broader coverage than most compounded GLP-1 telehealth providers
  • Board-certified obesity specialists with virtual consultations
  • 2-minute quiz onboarding — fast async approval path
  • 24/7 support with dedicated phone line
  • Katalys RevOffers tracking pixel detected — affiliate program active

Cons

  • Not available in Louisiana
  • Pricing not publicly disclosed on their website — requires completing the intake quiz
  • No visible LegitScript certification or PCAB accreditation
  • Compounded medications have not been reviewed or approved by the FDA (stated on their site)

NovoCare Pharmacy

Pros

  • First-party manufacturer pharmacy — the most authoritative branded Wegovy channel possible
  • $199/month intro pricing for Wegovy 0.25 mg and 0.5 mg starter doses (through 6/30/2026) is the lowest brand-name self-pay price for the FDA-approved Wegovy product
  • $349/month standard self-pay for full-dose Wegovy is well below the ~$1,300/month list price at retail pharmacies
  • Ships to all 50 states; no telehealth-platform middleman fees
  • Cold-chain logistics handled by Novo Nordisk directly — no risk of mishandling between manufacturer and patient
  • Insurance-billing path also available via the standard NovoCare savings program

Cons

  • Wegovy only — no semaglutide for type 2 diabetes (Ozempic), no compounded GLP-1, no tirzepatide
  • Requires an existing valid Wegovy prescription — NovoCare Pharmacy does not employ prescribing clinicians or operate a telehealth intake. You need a separate visit (PCP, endocrinologist, or another telehealth provider) to get the script first
  • $199 intro pricing is dose-restricted (0.25 mg / 0.5 mg only) and time-limited (through 6/30/2026) — most patients on the maintenance 1.7 / 2.4 mg dose pay $349/month
  • No clinical support included with the pharmacy fulfillment — your prescribing clinician handles titration and side-effect monitoring
  • Manufacturer-set pricing can change at any time

Our Verdict

Winner: NovoCare PharmacyScore: 8.7/10

NovoCare Pharmacy edges out Wellorithm with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. Wellorithm remains a solid alternative, especially if you're looking for compounded GLP-1 access with oral tablet options across 49 states.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring Wellorithm and NovoCare Pharmacy head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.